集成PCG光谱图纹理和深度特征用于诊断心力衰竭与保存的喷射分数使用异质堆叠合体学习
Yineng Zheng1,2, Jian Qin3, Fajin Lv1,2
1Department of Radiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Frontiers in physiology
|February 2, 2026
概括
一个新的集体学习模型有效地检测心力衰竭与保存的喷射分数 (HFpEF) 使用声心图 (PCG) 分析. 这种方法结合了纹理和深度特征,以改善计算机辅助诊断.
科学领域:
- 心脏病学和人工智能的人工智能
- 生物医学信号处理
- 医疗保健中的机器学习
背景情况:
- 保存喷射分数 (HFpEF) 的心力衰竭是一个关键的临床挑战.
- 精确检测HFpEF对于有效的慢性心力衰竭管理至关重要.
- 心电图 (PCG) 信号提供了有价值的诊断信息.
研究的目的:
- 为HFpEF检测开发一种新的异质堆叠集体学习模型.
- 为了融合心电图 (PCG) 谱图纹理和深度特征,提高诊断准确度.
- 评估模型的性能与基线和现有的深度学习方法相比.
主要方法:
- 使用Gammatone过器将PCG信号转换为2D光谱图.
- 开发了四种基本模型:纹理分析 (SVM与RFE) 和转移学习 (ResNet50,InceptionResNetV2,DenseNet121与RF-PCA).
- 一个异质堆叠组合模型与一个MLP元学习者集成的基础模型输出用于分类.
主要成果:
- 拟议的整体模型实现了高性能指标:AUC为0.933,准确度为0.902,灵敏度为0.958,特异性为0.843,精度为0.968,F1得分为0.923.
- 对HFpEF检测的基线和常见深度学习模型进行了持续的改进.
- 验证了基于PCG的HFpEF分析整体策略的有效性.
结论:
- 新型异质堆叠集体学习模型显示了计算机辅助诊断HFpEF的巨大潜力.
- 通过集体学习,PCG纹理和深度特征的融合增强了诊断能力.
- 这种方法为改善慢性心力衰竭的临床评估提供了一个有希望的途径.
相关概念视频
Heart Failure II: Pathophysiology
929
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
929
Pathophysiology of Heart Failure
3.7K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.7K
Heart Failure I: Introduction
886
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
886
Heart Failure VI: Adjunct Therapies
340
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
340
Heart Failure Drugs: Diuretics
971
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
971
Heart Failure V: Medical Management
319
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
319


